Monopar Therapeutics Inc (MNPR) Insider Trading
- $104,722.42
- $1,830,000.00
- Oct. 28, 2024
- Andrew Cittadine
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 28, 2024 | CFO | 1,550 | $16.25 | Buy | $25,187.50 | |
| June 20, 2024 | COO | 20,508 | $0.74 | Buy | $15,175.92 | |
| June 17, 2024 | COO | 12,000 | $0.90 | Buy | $10,800.00 | |
| June 13, 2024 | COO | 12,000 | $0.91 | Buy | $10,920.00 | |
| June 3, 2024 | COO | 12,000 | $0.76 | Buy | $9,120.00 | |
| May 31, 2024 | COO | 12,000 | $0.64 | Buy | $7,680.00 | |
| May 29, 2024 | COO | 12,000 | $0.64 | Buy | $7,680.00 | |
| Nov. 14, 2022 | COO | 6,053 | $3.00 | Buy | $18,159.00 | |
| Feb. 11, 2021 | Major Shareholder | 125,000 | $14.64 | Sell | $1,830,000.00 |
Insiders are both buying and selling Monopar Therapeutics Inc stock.
The insider traders at Monopar Therapeutics Inc are: Andrew Cittadine, Karthik Radhakrishnan, and Tactic Pharma Llc
The most active insider trader at Monopar Therapeutics Inc is Andrew Cittadine with 7 trades.
Tactic Pharma Llc has sold the most Monopar Therapeutics Inc stock with a total value of $3,660,000.00.
Andrew Cittadine has bought the most Monopar Therapeutics Inc stock with a total value of $94,710.84.
The most recent insider trade for Monopar Therapeutics Inc was on Oct. 28, 2024.
The single biggest insider buy for Monopar Therapeutics Inc was from Karthik Radhakrishnan with a total value of $25,187.50 on Oct. 28, 2024.
The single biggest insider sell for Monopar Therapeutics Inc was from Tactic Pharma Llc with a total value of $1,830,000.00 on Feb. 11, 2021.